Don't Just Read the News, Understand It.
Published loading...Updated

Revolutionary Blood Test Detects Pancreatic Cancer with 95% Accuracy, Mainz Biomed Study Reveals

Summary by stocktitan.net
New blood-based screening achieves 98% specificity in early pancreatic cancer detection. Mainz advances to feasibility phase with Crown Bioscience partnership. Learn more.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right

Distinguishing between malignancy and benignity in pancreatic cysts is not always possible with CT or MRI, and the only possibility of preventing Pancreatic Ductal Adenocarcinoma is surgical resection, which can carry serious risks. An innovative method aimed at the early detection of malignancy in the pancreas is being implemented at Aretaeio Hospital with the assistance of the National Research Foundation. The method is simple and is performed…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Tuesday, June 10, 2025.
Sources are mostly out of (0)